110 results
8-K
EX-4.2
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
8-K
EX-4.1
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
8-K
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
to the satisfaction of customary closing conditions. The Company intends to use these net proceeds received from the Inducement Transaction for general working capital
8-K
EX-10.1
vteoaj243zjhty
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
8-K
0rawkd zfn89
3 Jan 24
Changes in Registrant's Certifying Accountant
4:30pm
8-K
EX-10.1
j6wb8u ga
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-4.3
o40m 9y9pjrpj
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-4.2
p7xo6
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-99.1
fb43tlylnju 5al0
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-4.1
de6x2u0c7xu iu
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
424B5
qmkx7n wsd
2 Oct 23
Prospectus supplement for primary offering
4:52pm
8-K
EX-5.1
sx9aqiam6eu6 kl
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
8-K
ttobm vaobrw
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-1.1
xzh0vbzj
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-3.1
cti7cn9zhp6f
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm